Business alliance agreement for co-development of biosimilarsBusiness Alliance Agreement • June 18th, 2024
Contract Type FiledJune 18th, 2024Kidswell Bio Corporation (hereinafter “KWB”), headquartered in Tokyo, Japan and led by President & CEO Shinya Kurebayashi and Chiome Bioscience Inc. (hereinafter “Chiome”), headquartered in Tokyo, Japan and led by President & CEO Shigeru Kobayashi are pleased to announce that the two parties have entered into a business alliance agreement (the "Agreement") to promote the co-development of new biosimilars by combining the human resources and biopharmaceutical development expertise/experience of the two companies.